NCT00195286View on ClinicalTrials.gov

Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections.

CompletedOBSERVATIONAL

Enrollment

180

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Urinary Infections

Interventions

DRUG

piperacillin/tazobactam

Trial Locations (27)

Unknown

Antequera (Málaga)

Ávila

Barcelona

Berga (Barcelona)

Cadiz

Castellon

Cáceres

Ciudad Real

Cuenca

Ferrol

Granada

Jaén

Las Palmas

Lleida

Lorca (Murcia)

Lugo

Madrid

Osuna (Sevilla)

Palma Mallorca

Pamplona

Pontevedra

Terrassa

Torrelavega

Valencia

Valladolid

Vitoria-Gasteiz

Zaragoza

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195286 - Study Evaluating Piperacillin/Tazobactam in Complicated Urinary Infections. | Biotech Hunter | Biotech Hunter